Literature DB >> 16171853

Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats.

Ying Xu1, Bao-Shan Ku, Hai-Yan Yao, Yan-Hua Lin, Xing Ma, Yong-He Zhang, Xue-Jun Li.   

Abstract

Curcuma longa is a major constituent of Xiaoyao-san, the traditional Chinese medicinal formula, which has been used to effectively manage stress and depression-related disorders in China. Curcumin is the active component of curcuma longa, and we hypothesized that curcumin would have an influence on depressive-like behaviors. The purpose of the present study was to confirm the putative antidepressant effect of chronic administrations of curcumin (1.25, 2.5, 5 and 10 mg/kg, p.o.) in the forced swimming test and bilateral olfactory bulbectomy (OB) models of depression in rats. In the first study, chronic treatment with curcumin (14 days) reduced the immobility time in the forced swimming test. In the second experiment, curcumin reversed the OB-induced behavioral abnormalities such as hyperactivity in the open field, as well as deficits in step-down passive avoidance. In addition, OB-induced low levels of serotonin (5-HT), noradrenaline (NA), high 5-hydroxyindoleacetic acid (5-HIAA) and 4-dihydroxyphenylacetic acid (DOPAC) in the hippocampus were observed, and were completely reversed by curcumin administration. A slight decrease in 5-HT, NA and dopamine (DA) levels was found in the frontal cortex of OB rats which was also reversed by curcumin treatment. These results confirm the antidepressant effects of curcumin in the forced swim and the OB models of depression in rats, and suggest that these antidepressant effects may be mediated by actions in the central monoaminergic neurotransmitter systems.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16171853     DOI: 10.1016/j.pbb.2005.08.009

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  60 in total

1.  Protective effect of curcumin and its combination with piperine (bioavailability enhancer) against haloperidol-associated neurotoxicity: cellular and neurochemical evidence.

Authors:  Mahendra Bishnoi; Kanwaljit Chopra; Lu Rongzhu; Shrinivas K Kulkarni
Journal:  Neurotox Res       Date:  2010-11-13       Impact factor: 3.911

Review 2.  New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Authors:  Michael Maes; Zdenĕk Fišar; Miguel Medina; Giovanni Scapagnini; Gabriel Nowak; Michael Berk
Journal:  Inflammopharmacology       Date:  2012-01-24       Impact factor: 4.473

3.  The CB₁ receptor-mediated endocannabinoid signaling and NGF: the novel targets of curcumin.

Authors:  Parichehr Hassanzadeh; Anna Hassanzadeh
Journal:  Neurochem Res       Date:  2012-02-07       Impact factor: 3.996

Review 4.  Recent progress in the research field of neuropharmacology in China.

Authors:  Jin Li
Journal:  Cell Mol Neurobiol       Date:  2008-02-01       Impact factor: 5.046

5.  Viewpoint: mechanisms of action and therapeutic potential of neurohormetic phytochemicals.

Authors:  Mark P Mattson; Tae Gen Son; Simonetta Camandola
Journal:  Dose Response       Date:  2007-08-06       Impact factor: 2.658

6.  A novel PDE9 inhibitor WYQ-C36D ameliorates corticosterone-induced neurotoxicity and depression-like behaviors by cGMP-CREB-related signaling.

Authors:  Xian-Feng Huang; Wen-Tao Jiang; Li Liu; Fang-Chen Song; Xia Zhu; Gui-Lan Shi; Shu-Ming Ding; Heng-Ming Ke; Wei Wang; James M O'Donnell; Han-Ting Zhang; Hai-Bin Luo; Yi-Qian Wan; Guo-Qiang Song; Ying Xu
Journal:  CNS Neurosci Ther       Date:  2018-05-02       Impact factor: 5.243

7.  Antidepressant-like effects of ferulic acid: involvement of serotonergic and norepinergic systems.

Authors:  Jianliang Chen; Dan Lin; Chong Zhang; Gaowen Li; Nianping Zhang; Lina Ruan; Qizhi Yan; Jianxin Li; Xuefeng Yu; Xupei Xie; Cong Pang; Liang Cao; Jianchun Pan; Ying Xu
Journal:  Metab Brain Dis       Date:  2014-12-09       Impact factor: 3.584

8.  Ferulic acid increases pain threshold and ameliorates depression-like behaviors in reserpine-treated mice: behavioral and neurobiological analyses.

Authors:  Ying Xu; Lu Zhang; Tuo Shao; Lina Ruan; Lin Wang; Jiao Sun; Jianxin Li; Xinbo Zhu; James M O'Donnell; Jianchun Pan
Journal:  Metab Brain Dis       Date:  2013-04-14       Impact factor: 3.584

9.  The effect of curcumin on the brain-gut axis in rat model of irritable bowel syndrome: involvement of 5-HT-dependent signaling.

Authors:  Yingcong Yu; Shujuan Wu; Jianxin Li; Renye Wang; Xupei Xie; Xuefeng Yu; Jianchun Pan; Ying Xu; Liang Zheng
Journal:  Metab Brain Dis       Date:  2014-05-08       Impact factor: 3.584

10.  Appearance of antidepressant-like effect by sildenafil in rats after central muscarinic receptor blockade: evidence from behavioural and neuro-receptor studies.

Authors:  C B Brink; J D Clapton; B E Eagar; B H Harvey
Journal:  J Neural Transm (Vienna)       Date:  2007-09-07       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.